Moore Capital Management’s Boston Scientific BSX Stock Holding History

Moore Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.08M	Buy	+189,256	New	+$10.3M	0.12%	153
2023 Q2	–	Sell	-100,000	Closed	-$5M	–	526
2023 Q1	$5M	Buy	+100,000	New	+$4.71M	0.11%	158
2022 Q4	–	Sell	-479,888	Closed	-$18.6M	–	561
2022 Q3	$18.6M	Buy	+479,888	New	+$19.3M	0.44%	43
2022 Q2	–	Sell	-358,472	Closed	-$15.9M	–	703
2022 Q1	$15.9M	Buy	358,472 +14,330	+4%	+$621K	0.4%	41
2021 Q4	$14.6M	Buy	+344,142	New	+$14.5M	0.29%	72
2021 Q2	–	Sell	-556,409	Closed	-$21.5M	–	821
2021 Q1	$21.5M	Buy	556,409 +47,775	+9%	+$1.81M	0.27%	68
2020 Q4	$18.3M	Buy	508,634 +179,632	+55%	+$6.47M	0.2%	73
2020 Q3	$12.6M	Buy	329,002 +179,002	+119%	+$6.9M	0.24%	87
2020 Q2	$5.27M	Buy	+150,000	New	+$5.4M	0.14%	135

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Moore Capital Management's BSX Position: Q2 2026 in Review

Moore Capital Management opened a new position in Boston Scientific (BSX) in Q2 2026: 189,256 shares worth $8.08M. The stake represents 0.12% of the portfolio and ranks #153 among its holdings. This is a return to the name: Moore Capital Management previously reported a position in BSX as recently as Q1 2023.

Moore Capital Management first reported a position in BSX in Q2 2020 and has held it in 9 quarters since. The position peaked at $21.5M in Q1 2021. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Moore Capital Management held 189,256 shares of Boston Scientific worth $8.08M as of Q2 2026.
Boston Scientific was a new Moore Capital Management position in Q2 2026.
Boston Scientific made up 0.12% of Moore Capital Management's portfolio in Q2 2026, its #153 holding.
Moore Capital Management first reported a position in Boston Scientific in Q2 2020 and has held it in 9 quarters since.
Moore Capital Management's Boston Scientific position peaked at $21.5M in Q1 2021.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.